肝海绵状血管瘤:5年以上长期随访中增强动态CT或MRI的大小变化及决定因素
研究分析了101例肝海绵状血管瘤在60-157个月(中位81个月)随访期间的大小变化,发现31.7%增大、20.8%缩小,年轻患者增大更常见,肝硬化患者缩小趋势更高,除肝硬化和年龄外大小变化似乎为散发性。
要点
- 长期随访中约50%肝海绵状血管瘤大小变化超过初始直径20%。
- 年轻患者(平均47.3岁)病变增大比例更高,肝硬化患者缩小趋势更高。
- 仅1%病变在随访中出现大小波动。
核心结论
- 在5-13年长期随访中,约50%肝海绵状血管瘤增大或缩小超过初始直径20%;除肝硬化和年龄因素外,大小变化似乎为散发性。
研究设计与样本
- 回顾性分析1115例连续疑似肝血管瘤患者中101例有5年以上可比CT或MRI数据的患者;两名放射科医师独立在轴位图像上测量病灶最大径;参考标准为影像特征及随访大小变化分类(增大>120%、无变化80-120%、缩小<80%)。
诊断标准与关键数值
- 大小变化分类:增大为>120%初始直径,无变化为80-120%,缩小为<80%。
- 101个血管瘤中32个(31.7%)增大,21个(20.8%)缩小,随访间隔60-157个月(中位81个月)。
- 年轻患者增大更常见:平均年龄增大组47.3岁、无变化组52.8岁、缩小组合57.1岁,p=0.003。
- 15例肝硬化患者中病灶缩小7例、增大1例,缩小趋势更高(p=0.009);其他因素无统计学显著性(p>0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To investigate the very long-term (> 5 years) follow-up changes of hepatic cavernous hemangiomas and to evaluate possible determinant factors for the changes.
MATERIALS AND METHODS: Among 1115 consecutive patients suspected of having hepatic hemangiomas based on imaging features, 101 patients with comparable computed tomography or magnetic resonance imaging data during a 5-year follow-up interval in the Picture Archiving and Communication System were analyzed. Two radiologists independently determined the largest dimension of each lesion on axial images. In addition to background liver fibrosis or steatosis on imaging, histories of use of chemotherapeutic agents were checked from the patients' records. The final size change of the hemangioma was categorized into three groups compared with the initial diameter (increased, > 120%; no change, 80-120%; decreased, < 80%).
RESULTS: Among the 101 hemangiomas, 32 lesions (31.7%) were enlarged and 21 lesions (20.8%) were shrunken during intervals of 60-157 (median, 81) months. Younger patients showed a higher prevalence of lesion enlargement (mean age: enlarged, 47.3 years; no change, 52.8 years; shrunken, 57.1 years; p = 0.003). In 15 patients with cirrhosis, the lesions (shrunken, n = 7; enlarged, n = 1) showed a higher tendency of size decrease (p = 0.009), whereas other factors did not show statistical significance (p > 0.05). Only a minor proportion (1%, n = 1) of the lesions showed size fluctuation during follow-up.
CONCLUSION: During the long-term (5-13 years) follow-up, about 50% of the hepatic hemangiomas were enlarged or shrunken to > 20% of the initial diameter. Aside from the cirrhosis and aging factors, the size changes seemed sporadic.
引用
- Choi J, Yu JS, Cho ES, et al. Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change. Radiol Med. 2018. PMID: 29357040. doi:10.1007/s11547-018-0854-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。